Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 6, 2017. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9254-25
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)
- Initial Posting
- Nov 6, 2017
Reason
Demand increase for the drug